Average Insider

Where insiders trade, we follow

$KRRO
Frequency Therapeutics, Inc., a clinical-stage biotechnology company, focuses on developing therapeutics to activate a person's innate regenerative potential to restore function. Its Progenitor Cell Activation approach uses small molecules and activate progenitor cells within the body to create functional tissue. The company's lead product candidate is FX-322, which is in Phase IIa clinical trial to treat the underlying cause of sensorineural hearing loss. It is also developing medicines for patients across a range of degenerative conditions, including multiple sclerosis, and diseases of the muscle, gastrointestinal tract, skin, and bone. The company has a license and collaboration agreement with Astellas Pharma Inc. for the development and commercialization of FX-322, as well as collaboration and licensing agreements with Massachusetts Eye and Ear, the Massachusetts Institute of Technology, The Scripps Research Institute, and Cambridge Enterprises Limited. Frequency Therapeutics, Inc. was incorporated in 2014 and is headquartered in Lexington, Massachusetts.
Healthcare
Sector
Biotechnology
Industry
David L. Lucchino
CEO
46
Employees
$13.61
Current Price
$10.94M
Market Cap
52W Low$5.20
Current$13.6169.2% above low, 30.8% below high
52W High$17.35

Insider Activity Statistics

Aggregated buying and selling activity by time period
PeriodTypeInsidersTransactionsValueSharesBuy/Sell Ratio
1 weekBuys00--All Sells
Sells16$973,609.1066,632
2 weeksBuys00--All Sells
Sells16$973,609.1066,632
1 monthBuys14$884,751.9179,8091:1.10
Sells16$973,609.1066,632
2 monthsBuys14$884,751.9179,8091:1.10
Sells16$973,609.1066,632
3 monthsBuys14$884,751.9179,8091:2.44
Sells217$2,161,961.99151,448
See activity going back 12 months โ€” create a free account

Insider Transactions

Recent purchases and sales by company insiders
DateInsiderTypeSharesPriceValueActions
Nov 11, 2026
FORMELA JEAN FRANCOIS
Director
Sale2,984$15.60$46,550.40View Details
Nov 12, 2026
FORMELA JEAN FRANCOIS
Director
Sale6,870$14.30$98,241.00View Details
Nov 11, 2026
FORMELA JEAN FRANCOIS
Director
Sale19,042$15.00$285,630.00View Details
Nov 12, 2026
FORMELA JEAN FRANCOIS
Director
Sale33,175$14.30$474,402.50View Details
Nov 11, 2026
FORMELA JEAN FRANCOIS
Director
Sale3,944$15.00$59,160.00View Details
Nov 11, 2026
FORMELA JEAN FRANCOIS
Director
Sale617$15.60$9,625.20View Details
Oct 23, 2026
Lynx1 Capital Management LP
10% Owner
Purchase2,510$12.11$30,386.31View Details
Oct 26, 2026
Lynx1 Capital Management LP
10% Owner
Purchase25,124$11.75$295,091.43View Details
Oct 22, 2026
Lynx1 Capital Management LP
10% Owner
Purchase40,000$11.04$441,464.00View Details
Oct 22, 2026
Lynx1 Capital Management LP
10% Owner
Purchase12,175$9.68$117,810.17View Details
Sep 14, 2026
FORMELA JEAN FRANCOIS
Director
Sale6,602$14.12$93,220.24View Details
Sep 11, 2026
FORMELA JEAN FRANCOIS
Director
Sale8,450$13.99$118,215.50View Details
Sep 11, 2026
FORMELA JEAN FRANCOIS
Director
Sale1,750$13.99$24,482.50View Details
Sep 14, 2026
FORMELA JEAN FRANCOIS
Director
Sale31,888$14.12$450,258.56View Details
Sep 11, 2026
Dolan Oliver
Senior Vice President, Finance
Sale5$13.72$68.58View Details
Sep 9, 2026
Dolan Oliver
Senior Vice President, Finance
Sale6$13.60$81.62View Details
Sep 8, 2026
Dolan Oliver
Senior Vice President, Finance
Sale7,347$13.51$99,285.89View Details
Aug 26, 2026
FORMELA JEAN FRANCOIS
Director
Sale51$13.96$711.96View Details
Aug 26, 2026
FORMELA JEAN FRANCOIS
Director
Sale249$13.96$3,476.04View Details
Aug 19, 2026
FORMELA JEAN FRANCOIS
Director
Sale23,584$14.00$330,176.00View Details

Upcoming Earnings

Scheduled earnings reports
No upcoming earnings scheduled

Past Earnings

Historical earnings results
Nov 11, 2026
EPS
Estimated-$1.26
ActualN/A
Revenue
Estimated$187.50K
ActualN/A
2 more earnings records available โ€” create a free account to see 12 months of history
Version: v26.10.12